Data Foundry

Drug recalls 2021

Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC… — Class II drug recall D-0538-2021

Terminated recall by Cardinal Health Inc., reported 2021-06-02, distributed in FL, GA, SC. CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Recall numberD-0538-2021
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCardinal Health Inc., Dublin, OH, United States
Recall initiated2021-03-15
Classified2021-05-24
Reported by FDA2021-06-02
Terminated2024-06-17
DistributedFL, GA, SC
Quantity131 bottles
Reason classescgmp, temperature control
NDC49884-0561, 49884-0561-01, 49884-0561-05, 49884-0561-11, 49884-0562, 49884-0562-01, 49884-0562-05, 49884-0562-11, 49884-0563, 49884-0563-01, 49884-0563-05, 49884-0563-11, 49884-0564, 49884-0564-01, 49884-0564-05, 49884-0564-11, 49884-0604, 49884-0604-01, 49884-0604-05, 49884-0604-11, 49884-0605, 49884-0605-01, 49884-0605-05, 49884-0605-11

Product

Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang 317024 China For Par Pharmaceutical Companes, Inc. Spring Valley, NY 10977 U.S.A.

Reason for recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0538-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.